Managing Pulmonary Rehabilitation

Managing Pulmonary Rehabilitation

Structures pulmonary rehabilitation programs including exercise prescription with dyspnea-guided intensity, breathing retraining techniques, secretion clearance protocols, and outcome measurement using 6MWT, mMRC dyspnea scale, and COPD Assessment Test (CAT). Aligns with AACVPR and ATS/ERS pulmonary rehabilitation guidelines.

Why This Skill Exists

Pulmonary rehabilitation is an evidence-based intervention that reduces dyspnea, improves exercise tolerance, and decreases hospitalization rates for COPD by 25-30%. CMS covers pulmonary rehabilitation for moderate-to-severe COPD (GOLD stage II-IV), but requires documented medical necessity with PFT evidence, individualized treatment plans, and outcome measurement. Programs must balance exercise intensity with desaturation risk and dyspnea management. Poor documentation of oxygen titration during exercise, failure to track BODE index components, or omission of self-management education jeopardizes payer reimbursement and AACVPR program certification. This skill standardizes pulmonary rehab documentation for clinical safety and regulatory compliance.

Checkpoint A — Intake Verification

Before initiating pulmonary rehabilitation, confirm:

Required clinical questions:

• What is the pulmonary diagnosis and GOLD stage (for COPD)?
• What are the most recent pulmonary function test (PFT) results (FEV1, FVC, FEV1/FVC ratio, DLCO)?
• What is the patient's current oxygen prescription (liters/min, delivery device, continuous or PRN)?
• What is the patient's baseline dyspnea level using mMRC scale (0-4)?
• What are the comorbidities (cardiac disease, musculoskeletal limitations, anxiety/depression)?
• Has the patient had recent exacerbation, hospitalization, or change in respiratory status?

Required documents:

• Pulmonary function tests within 12 months
• Chest imaging (CXR or CT) if available
• ABG or SpO2 data at rest and with exertion
• Pulmonologist referral with diagnosis and oxygen prescription
• Current medication list (bronchodilators, ICS, systemic steroids, supplemental O2)
• CMS-required individualized treatment plan signed by physician

Step 1 — Classify Severity and Establish Baseline Metrics

GOLD classification for COPD:

• Stage I (Mild): FEV1 ≥80% predicted
• Stage II (Moderate): 50% ≤ FEV1 < 80% predicted
• Stage III (Severe): 30% ≤ FEV1 < 50% predicted
• Stage IV (Very severe): FEV1 <30% predicted

BODE Index (prognostic, track serially):

• BMI: ≤21 kg/m² = 1 point
• Obstruction: FEV1 % predicted (≥65=0, 50-64=1, 36-49=2, ≤35=3)
• Dyspnea: mMRC (0-1=0, 2=1, 3=2, 4=3)
• Exercise capacity: 6MWT (≥350m=0, 250-349=1, 150-249=2, ≤149=3)
• Total 0-10; higher scores predict increased mortality

Baseline assessments:

• 6MWT with SpO2 monitoring (continuous), Borg dyspnea (0-10), distance, rest breaks
• mMRC Dyspnea Scale: 0 (dyspnea only with strenuous exercise) to 4 (too breathless to leave house or breathless when dressing)
• CAT (COPD Assessment Test): 8-item, 0-40; ≥10 indicates significant symptom burden
• SGRQ (St. George's Respiratory Questionnaire) if available: 0-100; MCID = 4 units
• Maximal inspiratory pressure (MIP) if inspiratory muscle training planned

Step 2 — Prescribe Exercise with Dyspnea-Guided Intensity

Aerobic exercise prescription:

• Frequency: 2-3 supervised sessions/week for 36 sessions total (CMS coverage)
• Initial intensity: 60-80% of peak work rate from 6MWT or CPET; if unavailable, use symptom-limited approach
• Target dyspnea: Borg 3-5/10 (moderate-to-somewhat severe)
• Duration: 20-60 minutes per session (may start at 10-15 min intervals with rest breaks)
• Mode: Treadmill walking, cycle ergometer, Nu-Step, arm ergometry

Oxygen titration during exercise:

• Maintain SpO2 ≥88% (≥90% preferred) during exercise
• If SpO2 drops below 88%, increase O2 flow by 1 L/min increments
• Document resting O2 rate, exercise O2 rate, peak SpO2, and nadir SpO2
• Some patients need exercise O2 who do not require resting O2

Resistance training:

• 1-3 sets x 8-12 reps at 50-70% 1RM for major muscle groups
• Upper and lower extremity strengthening
• Focus on inspiratory muscles if MIP <60 cmH2O: threshold IMT device at 30% MIP, 15-30 min/day

Interval training option:

• For patients who cannot sustain continuous exercise: 30-60 seconds of high intensity alternating with 30-60 seconds rest
• Produces equivalent outcomes to continuous training with better tolerance

Step 3 — Implement Breathing Retraining and Secretion Management

Breathing techniques:

• Pursed-lip breathing (PLB): Inhale 2 seconds through nose, exhale 4 seconds through pursed lips; reduces respiratory rate and dynamic hyperinflation
• Diaphragmatic breathing: Place hand on abdomen, emphasize abdominal rise on inspiration; caution — not beneficial for all COPD patients, assess individually
• Paced breathing: Coordinate breathing with activities (exhale on exertion)
• Stacked breathing for chest expansion in restrictive disease

Secretion clearance techniques:

• Active cycle of breathing technique (ACBT): Breathing control → thoracic expansion exercises → forced expiratory technique (huffing)
• Positive expiratory pressure (PEP) devices: Acapella, Flutter, Aerobika
• Postural drainage with modified positions (avoid Trendelenburg if reflux, cardiac, or neurological contraindications)
• High-frequency chest wall oscillation (vest therapy) for bronchiectasis or CF

Energy conservation and activity modification (OT collaboration):

• Pacing strategies for ADLs (e.g., sit for grooming, rest between steps of dressing)
• Work simplification techniques
• Adaptive equipment recommendations (reacher, sock aid, shower chair)

Step 4 — Track Outcomes Serially

Assessment schedule:

• 6MWT: Baseline, mid-program (session 18), and discharge
  • MCID = 30 meters (conservative); 54 meters (original Redelmeier value)
  • Record SpO2, Borg dyspnea, HR, and rest breaks each test
• mMRC: Baseline and discharge (change of 1 grade is clinically meaningful)
• CAT: Baseline and discharge (MCID = 2 points)
• MIP: Baseline and discharge if IMT performed
• BODE Index: Baseline and discharge

Session documentation:

• Exercise modalities, duration, intensity (watts, speed, incline)
• SpO2 range (resting → nadir → recovery) with O2 flow rate
• Borg dyspnea and RPE at peak exercise
• Any adverse events (desaturation <85%, bronchospasm, hemoptysis, excessive dyspnea)
• Education topics covered (disease management, medication technique, action plan)

Step 5 — Prepare Discharge and Maintenance Plan

• Home exercise program with specific parameters matching achieved exercise capacity
• Oxygen prescription for home exercise if exercise desaturation documented
• Self-management action plan for exacerbation recognition and response
• Inhaler technique verification documented (>50% of patients use inhalers incorrectly)
• Smoking cessation resources if applicable
• Referral to maintenance program or community exercise group
• Follow-up PFT and pulmonology appointment scheduled
• Equipment needs: home O2, nebulizer, PEP device, pulse oximeter

Checkpoint B — Pre-Finalization Review

Before finalizing pulmonary rehabilitation documentation:

• GOLD stage and PFT values documented
• BODE index calculated at baseline
• Exercise prescription includes FITT parameters with dyspnea-guided intensity
• O2 titration during exercise documented with SpO2 targets
• Breathing retraining techniques specified and individualized
• 6MWT performed with full protocol (SpO2, Borg, distance, rest breaks)
• Session documentation includes hemodynamic and respiratory monitoring
• Self-management education documented per session
• Discharge plan includes home exercise, O2 needs, and follow-up
• CMS documentation requirements met (physician-signed treatment plan, outcome measures)

Quality Audit

• PFT values (FEV1, FVC, FEV1/FVC, DLCO) documented with date and percent predicted
• 6MWT uses standardized ATS protocol (30m course, standardized encouragement)
• SpO2 monitored continuously during 6MWT and exercise sessions
• Borg dyspnea scale used correctly (0-10 or 6-20 — specify which scale)
• Oxygen titration documented with resting and exercise flow rates
• Outcome measures compared to MCID thresholds for meaningful change
• BODE index components all measured and tracked
• All [VERIFY] flags resolved or escalated to pulmonologist
• Documentation meets AACVPR program certification standards
• Patient education documented with topics and competency assessment

Guidelines

• CMS covers pulmonary rehab for moderate-to-severe COPD with FEV1 <80% predicted and documented referral
• Programs must provide exercise, education, and psychosocial support per AACVPR standards
• The 6MWT is the most responsive outcome measure for pulmonary rehab — always use ATS standardized protocol
• Two 6MWTs at baseline are recommended (learning effect); use the better of the two
• SpO2 <88% during exercise requires O2 supplementation — never allow prolonged desaturation for "testing tolerance"
• Beta-agonist bronchodilator use 15-30 minutes before exercise improves exercise tolerance — coordinate with medication schedule
• Anxiety and depression are highly prevalent in COPD — screen with PHQ-9/GAD-7 and address in plan
• Exacerbation during the program requires medical clearance before resuming; document hold days
• Post-exacerbation pulmonary rehab within 4 weeks of discharge reduces re-hospitalization
• Pulmonary rehab benefits are not permanent — maintenance programs are essential for sustained gains; document recommendations